These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 29928367)
1. Quantitative proteomic analysis of the miR-148a-associated mechanisms of metastasis in non-small cell lung cancer. Chu D; Li J; Lin H; Zhang X; Pan H; Liu L; Yu T; Yan M; Yao M Oncol Lett; 2018 Jun; 15(6):9941-9952. PubMed ID: 29928367 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer. Li J; Yu T; Cao J; Liu L; Liu Y; Kong HW; Zhu MX; Lin HC; Chu DD; Yao M; Yan MX Cell Physiol Biochem; 2015; 37(5):1847-56. PubMed ID: 26584284 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419 [TBL] [Abstract][Full Text] [Related]
4. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer. Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168 [TBL] [Abstract][Full Text] [Related]
5. YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression. Su H; Fan G; Huang J; Qiu X Cell Signal; 2021 Sep; 85():110049. PubMed ID: 34082012 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells. Li J; Song Y; Wang Y; Luo J; Yu W Mol Cell Biochem; 2013 Aug; 380(1-2):277-82. PubMed ID: 23670799 [TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomic analysis of the metastasis-inhibitory mechanism of miR-193a-3p in non-small cell lung cancer. Deng W; Yan M; Yu T; Ge H; Lin H; Li J; Liu Y; Geng Q; Zhu M; Liu L; He X; Yao M Cell Physiol Biochem; 2015; 35(5):1677-88. PubMed ID: 25833338 [TBL] [Abstract][Full Text] [Related]
8. miR-148a promotes cell sensitivity through downregulating SOS2 in radiation-resistant non-small cell lung cancer cells. Zhang Y; Hu X Oncol Lett; 2022 Apr; 23(4):135. PubMed ID: 35251354 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-148a inhibits cell proliferation and cell cycle progression in lung adenocarcinoma via directly targeting transcription factor E2F3. Liu J; Si L; Tian H Exp Ther Med; 2018 Dec; 16(6):5400-5409. PubMed ID: 30546419 [TBL] [Abstract][Full Text] [Related]
10. microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition. Wang SH; Li X; Zhou LS; Cao ZW; Shi C; Zhou CZ; Wen YG; Shen Y; Li JK Tumour Biol; 2013 Dec; 34(6):3705-12. PubMed ID: 23873106 [TBL] [Abstract][Full Text] [Related]
11. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells. Mu J; Zhu D; Shen Z; Ning S; Liu Y; Chen J; Li Y; Li Z BMC Cancer; 2017 May; 17(1):307. PubMed ID: 28464803 [TBL] [Abstract][Full Text] [Related]
12. Retracted Article: MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells. Chen G; Ye L; Han Y; Han P RSC Adv; 2019 Jul; 9(37):21139-21146. PubMed ID: 35521334 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3. He M; Xue Y Onco Targets Ther; 2017; 10():1353-1361. PubMed ID: 28280370 [TBL] [Abstract][Full Text] [Related]
14. CircRNA 0009043 suppresses non-small-cell lung cancer development via targeting the miR-148a-3p/DNAJB4 axis. She K; Yu S; He S; Wang W; Chen B Biomark Res; 2022 Aug; 10(1):61. PubMed ID: 35974419 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226 [TBL] [Abstract][Full Text] [Related]
16. [Mechanism of long-chain noncoding RNA PCGEM1 in the regulation of the invasion and metastasis of oral squamous carcinoma cells via transforming growth factor β2/Smad2 signaling pathway]. Weng X; Li JS; Fan S Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Oct; 38(5):550-557. PubMed ID: 33085241 [TBL] [Abstract][Full Text] [Related]
17. Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer. Chen Y; Min L; Zhang X; Hu S; Wang B; Liu W; Wang R; Gu X; Shen W; Lv H; Zou J; Chen Y; Xu X; Chen L Oncol Rep; 2013 Oct; 30(4):1832-40. PubMed ID: 23843100 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner. Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934 [TBL] [Abstract][Full Text] [Related]
19. Wang K; Huang XT; Miao YP; Bai XL; Jin F Ann Transl Med; 2022 Nov; 10(22):1201. PubMed ID: 36544657 [TBL] [Abstract][Full Text] [Related]